Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Didier Benard is active.

Publication


Featured researches published by Didier Benard.


Journal of Medicinal Chemistry | 2002

SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2

Dominique Lesuisse; Gudrun Lange; Pierre Deprez; Didier Benard; Bernard Schoot; Georges Delettre; Jean-Pierre Marquette; Pierre Broto; Véronique Jean-Baptiste; Paulette Bichet; Edoardo Sarubbi; Eliane Mandine


Journal of Medicinal Chemistry | 2003

Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.

Gudrun Lange; Dominique Lesuisse; Pierre Deprez; Bernard Schoot; Petra Loenze; Didier Benard; Jean-Pierre Marquette; Pierre Broto; Edoardo Sarubbi; Eliane Mandine


Archive | 2007

Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors

Hartmut Strobel; Sven Ruf; Dominique Lesuisse; Conception Nemecek; Youssef El-Ahmad; Stefan Guessregen; Anne Lebrun; Kurt Ritter; Didier Benard; Augustin Hittinger; Herve Bouchard


Archive | 2006

Fluorene derivatives, composition containing said derivatives and the use thereof

Patrick Mailliet; Luc Bertin; Fabienne Thompson; Jean-Marie Ruxer; Fabienne Pilorge; Didier Benard; Hervé Minoux; Chantal Carrez; Hélène Goulaouic; Thierry Gouyon


Archive | 2004

Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors

Marcel Patek; Anil Nair; Augustin Hittinger; Conception Nemecek; Daniel Bond; Greg Harlow; Herve Bouchard; Jacques Mauger; Jean-Luc Malleron; Mark G. Palermo; Fahad Al-Obeidi; Thomas Faitg; Hartmut Strobel; Sven Ruf; Kurt Ritter; Youssef El-Ahmad; Dominique Lesuisse; Didier Benard


Journal of Medicinal Chemistry | 2002

Principles governing the binding of a class of non-peptidic inhibitors to the SH2 domain of src studied by X-ray analysis

Gudrun Lange; Dominique Lesuisse; Pierre Deprez; Bernard Schoot; Petra Loenze; Didier Benard; Jean-Pierre Marquette; Pierre Broto; Edoardo Sarubbi; Eliane Mandine


Biochemical and Biophysical Research Communications | 2002

High-affinity Src-SH2 ligands which do not activate Tyr527-phosphorylated Src in an experimental in vivo system

Eliane Mandine; Véronique Jean-Baptiste; Béatrice Vayssière; Dominique Gofflo; Didier Benard; Edoardo Sarubbi; Pierre Deprez; Roland Baron; Giulio Superti-Furga; Dominique Lesuisse


Archive | 2006

Isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities

Patrick Mailliet; Luc Bertin; Didier Benard; Chantal Carrez; Francois Vallee; Eric Bacque


Archive | 2001

Caprolactam derivatives and uses thereof

Pierre Deprez; Dominique Lesuisse; Didier Benard


Archive | 2008

Cyclic Urea Compounds, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors

Marcel Patek; Anil Nair; Augustin Hittinger; Conception Nemecek; Daniel Bond; Greg Harlow; Herve Bouchard; Jacques Mauger; Jean-Luc Malleron; Mark G. Palermo; Fahad Al-Obeidi; Thomas Faitg; Hartmut Strobel; Sven Ruf; Kurt Ritter; Youssef El-Ahmad; Dominique Lesuisse; Didier Benard

Collaboration


Dive into the Didier Benard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge